pembrolizumab
merck
['melanoma', 'pembro']
s1801 trial looking at neo- vs. adjuvant pembrolizumab for stage iii-iv melanoma by dr. sapna patel. striking efs benefits favoring pts using neoadjuvant pembro. presented at #esmo22 
A dedicated conference for oncology held under the theme "Access. Educate. Collaborate"